Latest Breaking News On - Pascalyne wilson - Page 2 : comparemela.com

Cellectis Receives Orphan Drug Designation for UCART22, its Allogeneic CAR T Product for

NEW YORK, June 04, 2024 (GLOBE NEWSWIRE) Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell

United statesNorth carolinaFrance generalNew yorkPatricia sosa navarroPascalyne wilsonMark frattiniAshleyr robinsonArthur strilEuropean medicines agencyCellectis the company euronext growthAmerican society of hematologyEuropean commissionSecurities exchange commissionEuropean unionCommittee for orphan medicinal products

Cellectis S A : Receives Orphan Drug Designation for UCART22, its Allogeneic CAR T Product for Patients with Acute Lymphoblastic Leukemia

PRESS RELEASE Cellectis Receives Orphan Drug Designation for UCART22, its Allogeneic CAR T Product for Patients with Acute Lymphoblastic.

France generalNorth carolinaUnited statesNew yorkPascalyne wilsonArthur strilSosa navarroSecurities exchange commissionAbout cellectisNasdaq global marketEuronext growthPrivate securities litigation reform actAnnual reportInterim chief financial officerLifesci advisors

Cellectis Reports Financial Results for First Quarter 2024

• Cellectis announced completion of the additional equity investment of $140M by AstraZeneca

United kingdomNorth carolinaUnited statesFrance generalNew yorkMarc dunoyerPatricia sosa navarroArthur strilAshleyr robinsonPascalyne wilsonBing wangResearch planAllogeneic car development programsGroup shareInternational accounting standards boardEuropean union

Cellectis Annual Shareholders General Meeting to be Held on June 28, 2024

NEW YORK, May 29, 2024 Cellectis , a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, announced today that it will.

New yorkUnited statesFrance generalNorth carolinaPatricia sosa navarroArthur strilPascalyne wilsonAshleyr robinsonCellectis the company euronext growthEuronext growthNasdaq global marketSosa navarroInterim chief financial officerLifesci advisors

Cellectis Annual Shareholders General Meeting to be Held

Cellectis Annual Shareholders General Meeting to be Held
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

France generalNorth carolinaUnited statesNew yorkPatricia sosa navarroAshleyr robinsonArthur strilPascalyne wilsonCellectis the company euronext growthEuronext growthNasdaq global marketSosa navarroInterim chief financial officerLifesci advisors